Quinoid Dihydropteridine Reductase (QDPR) (C-Term) Peptide
| Name | Quinoid Dihydropteridine Reductase (QDPR) |
| Synonyms | DHPR, PKU2, SDR33C1, FLJ42391, Dhpr, D5Ertd371e, 2610008L04Rik, QDPR, qdpr, MGC127076, MGC131372, CG4665, DmelCG4665 |
| Binding Site |
C-Term |
 |
1 reference available |
| Certificates | ISO 9001:2008 |
| Catalog no. | ABIN698468 |
| Quantity | 0.1 mg |
| Price | 49.50 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 2 to 3 Business Days |
Additional Information
| Immunogen | Synthetic peptide |
| Characteristics | Blocking peptide for QDPR (C-term) antibody ABIN652787 |
| Specificity | The synthetic peptide sequence used to generate the antibody AP8841b was selected from the C-term region of human QDPR. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
| Comments |
Background: QDPR is the enzyme dihydropteridine reductase, which catalyzes the NADH-mediated reduction of quinonoid dihydrobiopterin. This enzyme is an essential component of the pterin-dependent aromatic amino acid hydroxylating systems. |
Application Details
| Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles |
| Restrictions | For Research Use only |
Publications
| Product |
Schnetz-Boutaud, Anderson, Brown et al.: "Examination of tetrahydrobiopterin pathway genes in autism." in: Genes, brain, and behavior, Vol. 8, Issue 8, pp. 753-7, 2009 (PubMed).
|
